Dear PES Members,
Although the times are turbulent, it is important to recognize that we at PES have a lot to celebrate. Several things come to mind immediately:
-Our Annual meeting is just around the corner—May 15-18 at the National Harbor in Maryland. I look forward to seeing you there!
-PES received many, many applications for travel grants to the meeting, and we have agreed to fund 71 recipients. A record number!!
-The PedsENDO Discovery Program also received a record number of applications from medical students and early-year pediatric residents who are interested in attending the meeting. This year we are supporting 61 attendees. Another record number!! Thanks to the organizers of this Program and to all the members who have agreed to serve as mentors for the participants during the meeting. Even if you are not one of the formal mentors, please welcome these participants at the meeting and encourage them to become future pediatric endocrinologists.
-Along with the Annual Meeting, PES is also running our Board Review Course (with 56 attendees) as well as the Spring Retreat, which will include 24 fellows this year. Thanks to the organizers and faculty who are working to make both events successful. If you wanted to attend the Board Review Course but your schedule would not allow, please note that after the annual meeting the course materials will be available online for purchase.
-Below this text, please find the list of the winners of this year’s Junior Faculty Clinical Research Grants, Research Fellowship Grants, and Health Disparities Grants. Congratulations to these deserving awardees who are working to move our field and our clinical care forward.
-And finally, please also find below the list abstract awards as well as the list of those selected to present Presidential Posters this year. Please plan to attend these presentations and congratulate these authors on their great work. The Hormone Research in Pediatrics Award winners are listed too. So many wonderful things being done!
And if that is not enough, please see below for other news and PES-related activities/opportunities. As always, read all the way to the end; there are many things happening.
Kind Regards,
Mark Palmert, MD
2025 Grant Recipients
2025 PES and Human Growth Foundation Research Fellow Award – Lily Deng, Investigating Enteroendocrine Dysfunction in RFX6-MODY and PDX1-MODY, Cincinnati Children’s Hospital Medical Center
2025 PES Research Fellow Award – Bassem Shoucri, Investigating TSC22D2 in adipose tissue plasticity and type 2 diabetes, UCLA
2025 Fima Lifshitz Junior Faculty Clinical Research Grant – Raymond Kreienkamp, Leveraging Polygenic Scores to Improve the Clinical Care of Pediatric Diabetes, Boston Children’s Hospital
2025 PES Junior Faculty Research Grant – Kristie Aamodt, Defining the role of dysregulated lipid metabolism in impaired human alpha cell function in type 1 diabetes, Vanderbilt University Medical Center
2025 Health Systems Disparities Grant – Ayca Erkin-Cakmak, The Association Between Exposure to Neonicotinoids and Cardiometabolic Health in Mexican American Young Adults from the CHAMACOS Cohort, UCSF
2025 Health Systems Disparities Grant – Daniela Aguilar Abisad, Fighting Against Stigma and Discrimination in Pediatric Type 2 Diabetes, Stanford
2025 PES Award Winners
2025 AAP AND PES LEONA CUTTLER ABSTRACT AWARD-
Daniel Hammond, MD, Dia-beating Care Transitions: A Process Improvement Project for Preparation for Transition to Adult Care
2025 PAUL KAPLOWITZ ABSTRACT AWARD-
Alden Dewey, DO, Incidence of Adrenal Pathology in Children Referred for Premature Pubarche: A 9-year Retrospective Review in an Indiana Cohort
2025 HUMAN GROWTH FOUNDATION ABSTRACT AWARD-
Melanie Babinski, MD, Diagnostic Yield of Whole Exome Sequencing in Idiopathic Short Stature
PRESIDENTAL ABSTRACT AWARDS:
Priya Mohan, MD, Mary Barr, MD, Grace Bolly, Laura Golob, MD, Maya Yogev Lifshitz, MD, Ila Kacker, BA, Samson Cantor, BA, Sanjay Jumani, MD, Natali Borrego, MS, Sahara Hetherington, BA, Harry Liang, BA, Shreshta Banga, MD, Amanda Reese, MPH, Howard Chen, MS, Sheyla Zakashansky, Dwight Diaz Chambers, MD, PhD, Despoina Galetaki, MD
Hormone Research in Paediatrics Awards:
Best Novel Insight (Case Report) from North America published in HRP in 2024
Congenital Hyperinsulinism and Long QT Syndrome Attributable to a Variant in KCNE1 | Hormone Research in Paediatrics | Karger Publishers
Corresponding author: Dr. Diva De León-Crutchlow
Best Original Research from North America published in HRP in 2024
Copeptin Stimulation by Combined Intravenous Arginine and Oral LevoDopa/Carbidopa in Healthy Short Children and Children with the Polyuria-Polydipsia Syndrome | Hormone Research in Paediatrics | Karger Publishers
Corresponding author: Dr. Christine A. March
2025 PES Annual Meeting Not too late to register!
May 15-18, 20025 National Harbor, MD
How do you approach the older pediatric patient with hypoglycemia?
Attend the Meet the Professor session to learn the diagnostic approach to hypoglycemia and management outside of the newborn period.
Type 2 diabetes in childhood: Interested in the origins and outcomes?
There’s a symposium for that! Our experts review the lessons learned from large multicenter trials, outline the impact of maternal metabolism in pregnancy on newborn and childhood outcomes, and explore the application of metabolomics and precision medicine for treatment of childhood type 2 diabetes.
Is screening for MEN 1 and paraganglioma syndromes straightforward?
Join the experts at the SPARK session as they discuss the evidence for and controversies related to screening for MEN 1 and paraganglioma syndromes
And don’t miss the pre-conference workshop, Communication and Effective Feedback using a Competency-based Framework! Learn to give effective competency-based feedback to trainees. The workshop is open to all and specifically geared to give fellowship program directors and working in medical student, resident, and fellow education.
Register here: Pediatric Endocrine Society
Calling all members!
As we gear up for the annual meeting where the committees will meet in person to work on their annual work plans, we encourage you to get involved! If you have been wanting to contribute to your professional society and eager to make a difference, the annual meeting marks the rotation of committee terms, and we have many committees with new vacancies to fill, to name a few:
- Health Systems Disparity Committee
- Drugs & Therapeutics Committee
- Program Committee
- Spring Retreat -sub committee
- Website and Social Media Committee
Visit the website for the full list of committees, their charges and reach out today! The time is right to make a difference. Join a committee: Join a Committee – Pediatric Endocrine Society
Pediatric Subspecialty Recruitment Series – May 2025
CoPs (Council of Pediatric Subspecialties) and the APPD (Association of Pediatric Program Directors) will hold its 4th Annual Pediatric Subspecialty Recruitment Series in May 2025.
Sessions will be held May 6th, 8th, 13th, and 15th. All sessions will again be held 8-9:30 pm ET, given this is the only time that allows all regions to participate.
The series will feature informational subspecialty sessions where residents can visit virtual with multiple fellowship programs in their chosen subspecialty.
Click here for more information and to register: Pediatric Subspecialty Recruitment Series – Association of Pediatric Program Directors
New Drugs and Therapeutics Update: INVOKANA® (canagliflozin)
Prepared by Preneet Cheema Brar, MD, MS and Daniel Mak, MD.
New Drugs and Therapeutics Update: INVOKANA® (canagliflozin) – Pediatric Endocrine Society
MAP Spotlight: Soleno Therapeutics
Soleno Therapeutics, Inc., a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, is excited to announce that on March 26, 2025, the FDA has approved VYKAT XR (diazoxide choline) extended-release tablets, previously referred to as DCCR, for the treatment of hyperphagia in adults and children 4 years of age and older with Prader-Willi syndrome (PWS). VYKAT XR is available through the Soleno OneTM program, offering comprehensive patient support, at PANTHERx Rare Pharmacy.
About Prader-Willi Syndrome
Prader-Willi syndrome (PWS) is a rare genetic neurodevelopmental disorder caused by an abnormality in the gene expression on chromosome 15. The Prader-Willi Syndrome Association USA estimates that PWS occurs in one in every 15,000 live births. The defining symptom of PWS is hyperphagia, a chronic and life-threatening condition characterized by an intense persistent sensation of hunger accompanied by food preoccupations, an extreme drive to consume food, food-related behavior problems, and a lack of normal satiety.
C-US-VYK-00140 v1 04/2025
Read more: HOME | VYKAT XR (diazoxide choline) extended-release tablets for Healthcare Professionals
Soleno Therapeutics is part of the PES Mission Alliance Partnership. This announcement was prepared in compliance with PES guidelines to ensure objective educational content.
Online Education:
Did you know that we have great enduring content available on demand on our website? Check it out! Here is the calendar for webinars coming up: Events – Pediatric Endocrine Society. And below are links to access on demand sessions that have already taken place and can be viewed at your convenience!
- Industry Sponsored Symposia in variety of topics: PES Industry Sponsored Symposia Series – Pediatric Endocrine Society
- PES State of the Art Series: You can find the schedule for each month and access recordings of past webinars here: PES SIG State of the Art Series – Pediatric Endocrine Society
- The PES Education Committee Sponsored Webinar Series: covers hot topics/controversies in pediatric endocrinology and are presented by stalwarts in the field. These talks cover perspectives and discussions that are unlikely to be found in standard textbooks. The webinars are only offered to PES members and pediatric endocrinology trainees. PES Education Committee Webinar Series – Pediatric Endocrine Society
NIH Funding in Jeopardy: Call to Action from the Endocrine Society
Congress is in the process of determining funding for the National Institutes of Health (NIH) in fiscal year 2026. Funding for NIH is in serious jeopardy as many in Congress and the administration are seeking deep cuts to federally supported biomedical research.
The Endocrine Society is urging Congress to provide at least $51.303 billion for the NIH in FY 2026 and to ensure that funds are spent as they direct without any unauthorized recissions in both FY 2025 and FY 2026. It is imperative that every member of Congress hear from their constituents now about this important issue. Amplify the message from home by sending a message to your Congressional delegation in only a few clicks using their online campaign. It is critical that all Members of Congress need to hear these messages from their constituents before it’s too late.
Join us by taking action in the online campaign: secure.everyaction.com/PK0t2cj5NUyh_FYtjYKH3Q2
Health Systems Disparity Spotlight: Celebrating Asian American and Pacific Islander Heritage Month
Historical Tidbit: Henry R. Harrower, MD (April 30, 1883-January 2, 1953) Organotherapist
Submitted by Alan Rogol